Guangzhou Baiyunshan Pharmaceutical Stock Fundamentals
Guangzhou Baiyunshan Pharmaceutical fundamentals help investors to digest information that contributes to Guangzhou Baiyunshan's financial success or failures. It also enables traders to predict the movement of Guangzhou Pink Sheet. The fundamental analysis module provides a way to measure Guangzhou Baiyunshan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guangzhou Baiyunshan pink sheet.
Guangzhou |
Guangzhou Baiyunshan Pharmaceutical Company Profit Margin Analysis
Guangzhou Baiyunshan's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Guangzhou Baiyunshan Profit Margin | 0.06 % |
Most of Guangzhou Baiyunshan's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guangzhou Baiyunshan Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Guangzhou Baiyunshan Pharmaceutical has a Profit Margin of 0.0552%. This is 100.49% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 104.35% lower than that of the firm.
Guangzhou Baiyunshan Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Guangzhou Baiyunshan's current stock value. Our valuation model uses many indicators to compare Guangzhou Baiyunshan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Guangzhou Baiyunshan competition to find correlations between indicators driving Guangzhou Baiyunshan's intrinsic value. More Info.Guangzhou Baiyunshan Pharmaceutical is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies reporting about 0.28 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Guangzhou Baiyunshan Pharmaceutical is roughly 3.60 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Guangzhou Baiyunshan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Guangzhou Baiyunshan's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guangzhou Baiyunshan's earnings, one of the primary drivers of an investment's value.Guangzhou Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guangzhou Baiyunshan's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guangzhou Baiyunshan could also be used in its relative valuation, which is a method of valuing Guangzhou Baiyunshan by comparing valuation metrics of similar companies.Guangzhou Baiyunshan is currently under evaluation in profit margin category among related companies.
Guangzhou Fundamentals
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0356 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 5.65 B | |||
| Shares Outstanding | 219.9 M | |||
| Shares Owned By Institutions | 33.99 % | |||
| Price To Earning | 6.77 X | |||
| Price To Book | 0.78 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 69.01 B | |||
| Gross Profit | 13.19 B | |||
| EBITDA | 5.46 B | |||
| Net Income | 3.72 B | |||
| Cash And Equivalents | 21.72 B | |||
| Cash Per Share | 13.36 X | |||
| Total Debt | 752.81 M | |||
| Debt To Equity | 0.33 % | |||
| Current Ratio | 1.65 X | |||
| Book Value Per Share | 19.33 X | |||
| Cash Flow From Operations | 5.67 B | |||
| Earnings Per Share | 0.35 X | |||
| Number Of Employees | 25.44 K | |||
| Beta | 0.7 | |||
| Market Capitalization | 6.95 B | |||
| Total Asset | 66.12 B | |||
| Z Score | 6.4 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 66.12 B | |||
| Last Dividend Paid | 0.69 |
About Guangzhou Baiyunshan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guangzhou Baiyunshan Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guangzhou Baiyunshan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guangzhou Baiyunshan Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the Peoples Republic of China and internationally. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China. Guangzhou Baiyunshan operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 25437 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guangzhou Baiyunshan in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guangzhou Baiyunshan's short interest history, or implied volatility extrapolated from Guangzhou Baiyunshan options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Guangzhou Baiyunshan information on this page should be used as a complementary analysis to other Guangzhou Baiyunshan's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Guangzhou Pink Sheet analysis
When running Guangzhou Baiyunshan's price analysis, check to measure Guangzhou Baiyunshan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guangzhou Baiyunshan is operating at the current time. Most of Guangzhou Baiyunshan's value examination focuses on studying past and present price action to predict the probability of Guangzhou Baiyunshan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guangzhou Baiyunshan's price. Additionally, you may evaluate how the addition of Guangzhou Baiyunshan to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |